Who Funded LabCycle and How Much?

LabCycle, founded by Dr. Helen Liang (CTO) and Colin Francis (CEO), has raised capital through multiple instruments since 2022. The most recent £430,000 milestone is the combined total of a £180,000 investment from the British Design Fund (BDF) in June 2026 and a concurrent £250,000 Innovate UK Investment Partnership grant . The full list of known funders across all rounds includes:

• British Design Fund (BDF) — £180,000 (June 2026)
• QantX — led a £1M+ seed round (January 2026)
• Angel Investors Bristol — participated in the £1M+ seed round
• Angel Academe — participated in the £1M+ seed round and the Innovate UK-backed second close
• SFC Capital — led a £250K earlier round (2022) alongside 5 independent angels
• Innovate UK — multiple grants, including an Investment Partnership grant that brought LabCycle's cumulative total to £1.5M (June 2026)

The seed round, led by QantX in January 2026, was described as oversubscribed, indicating strong investor confidence in the technology and market need .

The Problem: 5.5 Million Tonnes of Incinerated Lab Plastic

LabCycle directly addresses a gap in global waste management. Unlike household plastics, laboratory and biomedical plastics are contaminated with biological or chemical hazards, which means they cannot enter standard recycling streams. As a result, the overwhelming majority is sent to incineration or landfill . The 5.5 million tonne annual figure cited by LabCycle covers the biomedical sector alone . Incineration of this waste produces significant CO₂ emissions — LabCycle estimates its AutoDecon system can reduce carbon emissions by up to 90% compared to incineration .

How AutoDecon Works: Low-Heat, Low-Pressure Decontamination

At the heart of LabCycle's solution is the Automated Decontamination System (AutoDecon). It is described as the world's first system capable of safely recycling contaminated lab plastics into high-grade resources without the high heat or pressure required by autoclaves . The process works by:

1. Collecting contaminated plastics from labs (BSL 1 & 2) and healthcare settings .
2. Sorting by plastic type (polypropylene, polystyrene, HDPE, etc.) .
3. Decontaminating via a proprietary low-temperature, low-pressure method that renders the waste safe to handle .
4. Reprocessing the material into high-grade polymer pellets .
5. Manufacturing new lab consumables, such as Petri dishes and test tubes, from those pellets .

LabCycle claims the process also minimises water usage by recycling water internally, further reducing the environmental footprint .

Vision: A Circular Economy for Scientific and Healthcare Sectors

LabCycle's stated core mission is to create the world's first truly circular supply chain for laboratory and medical plastic consumables . Rather than the current 'use and burn' linear model, the company envisions a closed-loop system where:

• Contaminated lab plastics are collected, decontaminated, and remanufactured into new lab-grade products
• The service scales beyond research labs into the NHS, commercial labs, and clinical settings
• Organisations can meet net-zero targets without compromising safety or operational efficiency

Key Milestones and Achievements

LabCycle has moved from concept to commercial operation in a few years, with several notable milestones.

NHS Engagement and Contracts:

• Accepted onto the NHS Innovation Accelerator (NIA) in 2025, enabling deployment across NHS trusts
• Awarded £99,992 by SBRI Healthcare in May 2024 to pilot a circular economy model for recycling single-use plastics from the NHS at a regional pilot site
• Currently operates under service contracts with NHS trusts, universities, and commercial laboratories

UK Startup Awards Recognition (2024):

• Regional winner for the South West at the UK StartUp Awards 2024
• Went on to win the national title: Clean Tech StartUp of the Year

Lab Innovations Award:

• LabCycle's 100% recycled polystyrene Petri dishes won the Best Consumable Innovation award at Lab Innovations

Operational Milestones:

• Opened the UK's first pilot plant for recycling lab plastic waste at the University of Bath in September 2023, capable of recycling up to 60% of lab plastic waste back into new consumables
• Completed a beta trial involving 23 researchers across 5 labs at the University of Bath, processing 155 kg of contaminated waste
• Total cumulative funding reached approximately £1.5M as of June 2026

Context and Caveats

While the environmental case for LabCycle's technology is strong, it is important to note a few constraints. The company is currently focused on Safety Level 1 & 2 labs and non-infectious healthcare waste . The AutoDecon system is still in early commercialisation; the company's own stated ambition is to recycle at least 40% (roughly 60,000 tonnes) of single-use lab plastic waste per year , a fraction of the 5.5 million tonne base. The claims that AutoDecon is the 'world's first' such system are primarily supported by the company itself and its investors .

Additionally, LabCycle has faced the standard risks of a deep-tech hardware startup: scaling from pilot to full commercial operations requires continuous funding and manufacturing partnerships. The company did confirm on LinkedIn in June 2026 that it would use the latest funding to 'boost recycling capacity' and 'expand specialist recycling technology' .

Who Funded LabCycle and How Much?

LabCycle, founded by Dr. Helen Liang (CTO) and Colin Francis (CEO), has raised capital through multiple instruments since 2022. The most recent £430,000 milestone is the combined total of a £180,000 investment from the British Design Fund (BDF) in June 2026 and a concurrent £250,000 Innovate UK Investment Partnership grant . The full list of known funders across all rounds includes:

• British Design Fund (BDF) — £180,000 (June 2026)
• QantX — led a £1M+ seed round (January 2026)
• Angel Investors Bristol — participated in the £1M+ seed round
• Angel Academe — participated in the £1M+ seed round and the Innovate UK-backed second close
• SFC Capital — led a £250K earlier round (2022) alongside 5 independent angels
• Innovate UK — multiple grants, including an Investment Partnership grant that brought LabCycle's cumulative total to £1.5M (June 2026)

The seed round, led by QantX in January 2026, was described as oversubscribed, indicating strong investor confidence in the technology and market need .

The Problem: 5.5 Million Tonnes of Incinerated Lab Plastic

LabCycle directly addresses a gap in global waste management. Unlike household plastics, laboratory and biomedical plastics are contaminated with biological or chemical hazards, which means they cannot enter standard recycling streams. As a result, the overwhelming majority is sent to incineration or landfill . The 5.5 million tonne annual figure cited by LabCycle covers the biomedical sector alone . Incineration of this waste produces significant CO₂ emissions — LabCycle estimates its AutoDecon system can reduce carbon emissions by up to 90% compared to incineration .

How AutoDecon Works: Low-Heat, Low-Pressure Decontamination

At the heart of LabCycle's solution is the Automated Decontamination System (AutoDecon). It is described as the world's first system capable of safely recycling contaminated lab plastics into high-grade resources without the high heat or pressure required by autoclaves . The process works by:

1. Collecting contaminated plastics from labs (BSL 1 & 2) and healthcare settings .
2. Sorting by plastic type (polypropylene, polystyrene, HDPE, etc.) .
3. Decontaminating via a proprietary low-temperature, low-pressure method that renders the waste safe to handle .
4. Reprocessing the material into high-grade polymer pellets .
5. Manufacturing new lab consumables, such as Petri dishes and test tubes, from those pellets .

LabCycle claims the process also minimises water usage by recycling water internally, further reducing the environmental footprint .

Vision: A Circular Economy for Scientific and Healthcare Sectors

LabCycle's stated core mission is to create the world's first truly circular supply chain for laboratory and medical plastic consumables . Rather than the current 'use and burn' linear model, the company envisions a closed-loop system where:

• Contaminated lab plastics are collected, decontaminated, and remanufactured into new lab-grade products
• The service scales beyond research labs into the NHS, commercial labs, and clinical settings
• Organisations can meet net-zero targets without compromising safety or operational efficiency

Key Milestones and Achievements

LabCycle has moved from concept to commercial operation in a few years, with several notable milestones.

NHS Engagement and Contracts:

• Accepted onto the NHS Innovation Accelerator (NIA) in 2025, enabling deployment across NHS trusts
• Awarded £99,992 by SBRI Healthcare in May 2024 to pilot a circular economy model for recycling single-use plastics from the NHS at a regional pilot site
• Currently operates under service contracts with NHS trusts, universities, and commercial laboratories

UK Startup Awards Recognition (2024):

• Regional winner for the South West at the UK StartUp Awards 2024
• Went on to win the national title: Clean Tech StartUp of the Year

Lab Innovations Award:

• LabCycle's 100% recycled polystyrene Petri dishes won the Best Consumable Innovation award at Lab Innovations

Operational Milestones:

• Opened the UK's first pilot plant for recycling lab plastic waste at the University of Bath in September 2023, capable of recycling up to 60% of lab plastic waste back into new consumables
• Completed a beta trial involving 23 researchers across 5 labs at the University of Bath, processing 155 kg of contaminated waste
• Total cumulative funding reached approximately £1.5M as of June 2026

Context and Caveats

While the environmental case for LabCycle's technology is strong, it is important to note a few constraints. The company is currently focused on Safety Level 1 & 2 labs and non-infectious healthcare waste . The AutoDecon system is still in early commercialisation; the company's own stated ambition is to recycle at least 40% (roughly 60,000 tonnes) of single-use lab plastic waste per year , a fraction of the 5.5 million tonne base. The claims that AutoDecon is the 'world's first' such system are primarily supported by the company itself and its investors .

Additionally, LabCycle has faced the standard risks of a deep-tech hardware startup: scaling from pilot to full commercial operations requires continuous funding and manufacturing partnerships. The company did confirm on LinkedIn in June 2026 that it would use the latest funding to 'boost recycling capacity' and 'expand specialist recycling technology' .